Vifor Pharma Group announced the appointment of Patrick Treanor as President of Relypsa on a permanent basis. He is also appointed to the Executive Committee of Vifor Pharma Group with immediate effect. Patrick was appointed interim President of Relypsa, the US affiliate of Vifor Pharma Group on 20 September 2018. Patrick was appointed interim President of Relypsa, the US affiliate of Vifor Pharma Group on 20 September 2018. Patrick joined Relypsa in 2015 to establish the sales organisation for the US launch of Veltassa. In April 2017, he was appointed Senior Vice President and Chief Commercial Officer of Relypsa and has been instrumental in leading the commercialisation strategy of Veltassa and driving Relypsa to achieve its goal of becoming a leader in nephrology and cardio-renal therapies.